Background & objectives:
The global spread of carbapenem-resistant
Enterobacteriaceae
(CRE) is an emerging clinical problem. Hence, in this study, the plausible role of extended-spectrum beta-lactamases (ESBLs)/carbapenemases, OmpC/Ompk36,
acrB
and their combinations was explored among CRE.
Methods:
The minimum inhibitory concentration (MIC) of meropenem, enzyme-phenotypes (ESBLs/IR and metallo-beta-lactamase (MBL)/non-MBL carbapenemase), genotypes (
bla
TEM,
bla
SHV
and
bla
CTX-M
;
bla
NDM
and
bla
VIM;
bla
KPC
and
bla
OXA-48
-like variants),
acrB
and outer membrane protein (OMP) expressions were analyzed with a total of 101 non-duplicate clinical isolates, obtained from various samples of patients visiting two tertiary care units of Eastern India during May 2013 - October 2016. This included
Escherichia coli
(n=36) and
Klebsiella pneumoniae
(n=65), categorized into two groups, namely Group I (resistant to all carbapenems; n=93;
E. coli
=34 and
Klebsiella
spp.=59) and Group II (non-resistant to all the carbapenems; n=8;
E. coli
=2 and
Klebsiella
spp.=6).
Results:
Though 88.17 per cent of Group I isolates exhibited ESBL property, the presence of carbapenemase activity (70.96%) and that of
bla
NDM
gene (42/66: 63.63%) indicated their contributions towards the emergence of CRE. Further, porin loss and/or efflux pump activation among ESBL/carbapenemase-producing isolates heightened the MIC of meropenem from 64 to 256 mg/l (range exhibited by only ESBL/carbapenemase-producing isolates) to >256 mg/l.
Interpretation & conclusions:
These findings implied the major contribution of porin loss and/or efflux pump activation over the presence of ESBLs/carbapenemases in imparting carbapenem resistance in pathogenic bacteria.